Browsing by Subject "Biomarker"

Now showing items 1-5 of 5

    • Editorial: Novel biomarkers for type 2 diabetes 

      Ahluwalia T.S.; Kilpel�inen T.O.; Singh S.; Rossing P. (Frontiers Media S.A., 2019)
      [No abstract available]

    • The journey of noncoding RNA from bench to clinic 

      Chhabra, Ravindresh (Elsevier, 2021-01-30)
      The discovery of noncoding RNA (ncRNA) in the 90s completely changed our understanding of gene regulation. The ncRNAs specialize in regulating the gene expression, which enables them to induce a remarkable change in cellular ...

    • LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3 

      Sharma, Uttam; Barwal, Tushar Singh; Khandelwal, Akanksha; Malhotra, Akshay; Rana, Manjit Kaur; Singh Rana, Amrit Pal; Imyanitov, Evgeny N.; Vasquez, Karen M.; Jain, Aklank (Elsevier B.V., 2021-01-11)
      Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with fewer treatment options than other types of invasive breast cancer due to the loss of the estrogen, progesterone receptors and low ...

    • miR-590�5p: A double-edged sword in the oncogenesis process 

      Barwal, Tushar Singh; Singh, Neha; Sharma, Uttam; Bazala, Sonali; Rani, Medha; Behera, Alisha; Kumawat, Ram Kumar; Kumar, Pawan; Uttam, Vivek; Khandelwal, Akanksha; Barwal, Jyoti; Jain, Manju; Jain, Aklank (Elsevier Ltd, 2022-06-12)
      Accumulating evidence suggests the critical role of miR-590�5p in various aspects of cellular homeostasis, including cancer. Furthermore, we and others have recently demonstrated that miRNA-590�5p acts as an oncogene in ...

    • Potential clinical application of lncRNAs in pediatric cancer 

      Chhabra, Ravindresh; Neyol, Priyasha; Bazala, Sonali; Singh, Ipsa; Murmu, Masang; Sharma, Uttam; Barwal, Tushar Singh; Jain, Aklank (Elsevier, 2022-01-28)
      Cancer is the leading cause of death by disease in children globally. The childhood cancer burden is more than 80% in the low- and middle-income countries, including India. In contrast to cancer in adults, the number of ...